Aeterna Zentaris (NASDAQ:AEZS) Stock Rating Reaffirmed by HC Wainwright
HC Wainwright reaffirmed their buy rating on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a report issued on Friday morning, Benzinga reports. HC Wainwright currently has a $28.00 target price on the biopharmaceutical company’s stock. Separately, StockNews.com initiated coverage on Aeterna Zentaris in a research note on Sunday, July 9th. They set […]